NYSE:AVNS
Avanos Medical Inc. Stock News
$18.08
-0.540 (-2.90%)
At Close: Apr 30, 2024
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
12:04am, Wednesday, 22'nd Feb 2023
Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. (AVNS) Q4 2022 Earnings Call Transcript
12:30pm, Tuesday, 21'st Feb 2023
Avanos Medical, Inc. (NYSE:AVNS ) Q4 2022 Earnings Conference Call February 21, 2023 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy and M&A Joe Woody - Chief Executive
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
10:32am, Tuesday, 21'st Feb 2023
Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial Results
05:49am, Tuesday, 14'th Feb 2023
ALPHARETTA, Ga. , Feb. 14, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full
Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
02:36pm, Wednesday, 04'th Jan 2023
ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
09:47am, Friday, 09'th Dec 2022
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
12:03pm, Thursday, 08'th Dec 2022
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos: TriVisc Offering Appealing, Strong Growth Across Rest Of Product Portfolio, Revise To Buy
01:45am, Tuesday, 06'th Dec 2022
Revenue for the third quarter 2022 was $202mm, up 9.8% compared to last year. Substantial uplift in operating income, fetching $27mm, representing YoY growth of ~59%.
Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?
12:48pm, Friday, 02'nd Dec 2022
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos Medical, Inc. to Present at the Stifel 2022 Healthcare Conference
03:41pm, Tuesday, 08'th Nov 2022
ALPHARETTA, Ga. , Nov. 8, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financia
Avanos Medical, Inc. (AVNS) Q3 2022 - Earnings Call Transcript
01:08am, Saturday, 05'th Nov 2022
Avanos Medical, Inc. (NYSE:AVNS ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Scott Galovan - Vice President, Corporate Strategy and Business Development Joseph W
Avanos (AVNS) Q3 Earnings Surpass Estimates, Margins Up
01:34pm, Friday, 04'th Nov 2022
Avanos' (AVNS) third-quarter 2022 results reflect strength in the Pain Management segment.
Avanos Medical (AVNS) Tops Q3 Earnings Estimates
09:48am, Wednesday, 02'nd Nov 2022
Avanos Medical (AVNS) delivered earnings and revenue surprises of 5.56% and 1.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for October 5th
08:17am, Wednesday, 05'th Oct 2022
AVNS, NKE and PLAB have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2022.
New Strong Sell Stocks for September 28th
08:17am, Wednesday, 28'th Sep 2022
AVNS, ARCE and DCO have been added to the Zacks Rank #5 (Strong Sell) List on September 28, 2022.
